This inventor holds 1 USPTO granted patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Helen Payne and Her Patent in Multispecific Antigen-Binding Proteins.
Introduction
Helen Payne is an inventor associated with Collegeville, Pennsylvania, and with intellectual property development at GlaxoSmithKline. Her listed patent concerns multispecific antigen-binding proteins.
Latest Patents
Payne is credited with 1 patent: “IL-18/IL-23 Multispecific Antigen Binding Proteins.” The invention relates to antigen-binding proteins designed to target both IL-18 and IL-23.
Career Highlights
Payne’s recorded patent activity connects her work to biopharmaceutical research and intellectual property development. The available information identifies her as an inventor on the patent and associates her with GlaxoSmithKline Intellectual Property Development Limited.
Collaborations
Sunil Nagpal and Yanxia Guo are listed as Payne’s coworkers, reflecting a professional network connected to her work.
Conclusion
Helen Payne’s patent record highlights her contribution to multispecific antigen-binding protein innovation in the biopharmaceutical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile